** Shares of healthcare technology co Aclarion ACON.O rise 68% to $5.61 premarket
** Co says it has entered into commercial agreement with Scripps Health
** The agreement will bring ACON's Nociscan, a tool that helps physicians personalize treatment for chronic low back pain, to Scripps' physicians in California
** In the last 12 months, ACON has fallen nearly 98%
(Reporting by Siddhi Mahatole)
((Siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。